SV Life Sciences Advisers

Latest statistics and disclosures from SV Health Investors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BCYC, BVS, XFOR, ASXC, and represent 100.00% of SV Health Investors's stock portfolio.
  • Reduced shares in these 1 stock: AHCO (-$18M).
  • Sold out of its position in AHCO.
  • SV Health Investors was a net seller of stock by $-18M.
  • SV Health Investors has $32M in assets under management (AUM), dropping by -26.32%.
  • Central Index Key (CIK): 0001587143

Tip: Access up to 7 years of quarterly data

Positions held by SV Life Sciences Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for SV Health Investors

SV Health Investors holds 4 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bicycle Therapeutics Sponsored Ads (BCYC) 65.4 $21M 907k 23.26
 View chart
Bioventus Inc - A (BVS) 32.3 $10M 1.5M 7.00
 View chart
X4 Pharmaceuticals (XFOR) 1.6 $532k 312k 1.71
 View chart
Asensus Surgical Com New (ASXC) 0.7 $229k 510k 0.45
 View chart

Past Filings by SV Health Investors

SEC 13F filings are viewable for SV Health Investors going back to 2014

View all past filings